Washington: US President Donald Trump has announced that imported generic medicines will remain free of tariffs for two years from August 1, 2026, before facing duties of 100 per cent and later 200 per cent as part of his push to shift pharmaceutical production to the United States. Two-Year Tariff-Free Window for Generic Drug Imports.
